Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9005229 | Clinical Therapeutics | 2005 | 10 Pages |
Abstract
When considering treatment choices for patients with OAB, particularly the elderly, the potential CNS adverse effects of each anticholinergic agent must be weighed against the severity of OAB symptoms.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
PharmD, FCCP Scheife, MD Takeda,